Es Oxali 100 Injection
Marketer
Esperer Bioresearch Pvt Ltd
Salt Composition
Oxaliplatin (100mg)
Overview Es Oxali 100 Injection
Oxaliplatin 100mg Injection treats colorectal cancer by inhibiting or reducing cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; improper usage can lead to severe adverse reactions. Therapeutic effects may not be immediately apparent, potentially taking weeks or months; discontinue only under medical guidance. Common side effects include nausea, tiredness, vomiting, and diarrhea. This medication can lower blood cell counts (red and white), increasing infection risk. Serious allergic reactions, such as mouth sores, rashes, itching, or breathing difficulties, necessitate immediate medical attention. Regular blood tests monitoring blood cell counts, heart, liver function, and uric acid levels are essential. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent medications, particularly those for infections. Interactions with other drugs are possible; disclose all medications to your healthcare provider. Use during pregnancy or breastfeeding is contraindicated. Male infertility is a potential side effect; sperm freezing should be discussed with your doctor prior to treatment. Drowsiness may occur; avoid driving after administration.
Uses of Es Oxali 100 Injection
Colorectal cancer
Major Benefits of Es Oxali 100 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Es Oxali 100 Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Es Oxali 100 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Es Oxali 100 Injection works:
Oxali 100 Injection is a cancer therapeutic agent. Its mechanism of action involves disrupting the genetic structure (DNA and RNA) within cancerous cells, thereby halting their proliferation and expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Es Oxali 100 Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Es Oxali 100 Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may exist in critical circumstances where a physician deems the potential advantages outweigh the hazards. Always seek medical counsel.
Breast feedingUNSAFE
Administering Es Oxali 100 Injection while breastfeeding is contraindicated due to potential infant toxicity. Studies indicate a risk of harmful effects to the nursing infant.
DrivingUNSAFE
Es Oxali 100 Injection, like other oxaliplatin-based therapies, can induce adverse reactions. These may include dizziness, nausea, vomiting, and other neurological effects impacting gait, potentially impairing driving ability.
KidneyCAUTION
Es Oxali 100 Injection requires careful administration in individuals with advanced renal impairment. Dosage modification for Es Oxali 100 Injection might be necessary. Physician consultation is advised. Data regarding Es Oxali 100 Injection use in such patients is limited. Dosage alteration isn't suggested for those with mild or moderate kidney disease.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Es Oxali 100 Injection. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Es Oxali 100 Injection :
Should you forget a dose of Es Oxali 100 Injection, seek medical advice.
Facts to Know About Es Oxali 100 Injection
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Platinum-based anticancer agents |
3,018 People bought this recently